Astrana Health Discounted Cash Flow Analysis

This is a news story, published by Yahoo Finance (Canada), that relates primarily to DCF news.

banking & finance news

For more banking & finance news, you can click here:

more banking & finance news

Yahoo Finance (Canada) news

For more news from Yahoo Finance (Canada), you can click here:

more news from Yahoo Finance (Canada)

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best business news, entertainment news, world news, and much more. If you like banking & finance news, you might also like this article about

Astrana Health

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest equity analysis news, analyst estimates news, banking & finance news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

fair value estimate

Simply Wall St

•

Is Astrana Health, Inc. (NASDAQ:ASTH) Trading At A 23% Discount?

Summary

Nutrition label

84% Informative

Astrana Health's US$ 54.47 share price signals that it might be 23% undervalued.

Analyst price target for ASTH is US$ 61.86 which is 12% below our fair value estimate.

We're using the 2 -stage growth model, which simply means we take in account two stages of company's growth.

We discount future cash flows to today 's value using the Discounted Cash Flow ( DCF ) model.

The total value, or equity value, is then the sum of present value of the cash flows.

DCF does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of potential performance.

The DCF model is not a perfect stock valuation tool.

Instead the best use for the model is to test certain assumptions and theories to see if they would lead to the company being undervalued or overvalued.

For example, we've discovered 1 warning sign for Astrana Health that you should be aware of before investing.

VR Score

Informative language

Neutral language

Article tone

informal

Language

English

Language complexity

Offensive language

not offensive

Hate speech